Steven Leh, MD
Pulmonary Disease · Milwaukee, WINPI 1780790030
Payments from drug & device makers
What this record shows
This record is dominated by education: $30,000 of the $39,579 with a category attached, or 75.8%. Intuitive Surgical accounts for 81.1% of it on its own, with 3 other manufacturers making up the rest. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $1164.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$32K
- Pleural Dynamics Inc.$5K
- Pulmonx Corporation$2K
- Steris Corporation$100
What the payments were for
- Consulting fees$5,23813%
- Travel & lodging$2,4346%
- Food & beverage$1,7684%
- Education$30,00076%
- Gifts$1400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 26 | $32,093 |
| Pleural Dynamics Inc. | 4 | $5,130 |
| Pulmonx Corporation | 3 | $2,256 |
| Steris Corporation | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$28,956
- Automatic Continuous Effusion Shunt (ACES) System$5,130
- ION$3,000
- ZEPHYR ENDOBRONCHIAL VALVE$2,256
- ZEPHYR DELIVERY CATHETER$1,663
- CHARTIS CATHETER$1,663
- PULMONX CHARTIS TABLET CONSOLE$1,663
- TRUFREEZE$100
How this compares
$39,579 in reported general payments places this provider in the 95th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 17 | $215,294 |
| ArikayceAmikacin Liposomal/Neb.Accessr | 12 | $183,490 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 158 | $131,358 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 64 | $32,705 |
| Breo ElliptaFluticasone/Vilanterol | 51 | $26,755 |
| Spiriva HandihalerTiotropium Bromide | 20 | $16,453 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 21 | $16,228 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $11,588 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $4,892 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $3,184 |
| Qvar RedihalerBeclomethasone Dipropionate | 13 | $3,116 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,836 |
| Roflumilast | 25 | $2,084 |
| Ethambutol Hcl | 31 | $1,483 |
| Ventolin HfaAlbuterol Sulfate | 11 | $1,135 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Milwaukee
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
- Rahul NanchalMilwaukee$42K
- Ali MusaniMilwaukee$38K
- Michael KatzoffMilwaukee$37K
- Uzair GhoriMilwaukee$32K
- Jayshil PatelMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.